ASKA Pharmaceutical Holdings (4886) · InitiativeRaised
Flexible capital policy through share repurchases
First written in FY2022. 1 of 4 entries say "Advanced", first in 2026-05-11. Latest entry: FY2026.
4entries
5years
1from disclosures
How it moved
Same theme, other companies
Flexible shareholder returns and capital policy through Board authorityA theme 412 companies write about · 0 as a headwind · 413 as a tailwind
1 other company's latest entry also says "Raised".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 199 companies compared. The sentences above are computed from all 199.Comparing 200 of the theme's 413 threads.Full recordFilings, disclosures and news, newest first
- FY2026RaisedAnnual report
「We will consider flexible share repurchases with a target total payout ratio of 40%.」
In addition to past share repurchases and cancellations, the company states that it will consider share repurchases flexibly during the period of Medium-Term Management Plan 2028, targeting a total payout ratio of 40%. - 2026-05-11AdvancedDividends
「Under the Medium-Term Management Plan 2028 beginning in the fiscal year ending March 2027, we will consider purchasing treasury shares flexibly, targeting a total payout ratio of 40%.」
The company stated a policy of considering flexible treasury-share purchases during the Medium-Term Management Plan 2028 period, in addition to past purchases and cancellations. No actual purchase decision was disclosed. - FY2025Treasury shares cancelledAnnual report
「消却の処分を行った取得自己株式 1,800,000 発行済株式総数の減少は、自己株式の消却によるものであります。」
機動的な資本政策に関連して、2025年3月に自己株式1,800,000株を消却し、発行済株式総数を30,563,199株から28,763,199株へ減少させた。 - FY2022First statedAnnual report
「取締役会（2021年7月12日）での決議状況（取得期間 2021年8月3日～2022年3月31日） 300,000株 350,000,000円」
機動的な資本政策の一環として、2021年8月から2022年3月までに30万株を上限とする自己株式取得決議と、実際の取得額を初めて記載している。